Summary
This prediction ended on 09.11.18 with a price of €18,400,000. Massive losses of -33.33% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Neovacs | - | - | - | - |
| iShares Core DAX® | 0.760% | -0.301% | 17.507% | 63.360% |
| iShares Nasdaq 100 | 0.732% | -1.001% | 9.349% | 98.401% |
| iShares Nikkei 225® | 1.025% | -3.621% | 12.862% | 44.355% |
| iShares S&P 500 | -0.036% | -0.194% | 3.758% | 60.186% |
According to melinda what are the pros and cons of Neovacs for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Neovacs diskutieren
(Vom Mitglied beendet)